,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['bcsm', 'lung', 'breast', 'enhertu']
promising development for those w/ #her2low #breastcancer but ... there were #ses for some.
"around 12% of patients who were treated w/enhertu developed a lung disease."
#bcsm
___________________________
#asco22: enhertu blows chemotherapy out of the water 
Everything was going great until this whole breast cancer thing.